Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin polymerization protein subunit beta class I (TUBB) is a key component of microtubules, which are essential for cell division, intracellular transport, and cell shape. It is a major drug target for anti-mitotic chemotherapeutics like paclitaxel, colchicine and vinca alkaloids, which disrupt microtubule dynamics and spindle formation, leading to apoptosis of rapidly dividing cells. Mutations in TUBB can disrupt vesicle trafficking or alter microtubule dynamics, leading to disease phenotypes.
Inhibition of tubulin polymerization, disruption of microtubule dynamics, disruption of spindle formation during cell division
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin polymerization protein subunit beta class I.